Physiology and Pathophysiology of the Adipose Tissue Renin-Angiotensin System

Cited by (474)

Items 101–200 of 474

1. Obesity and hypertension
   Fadi A El-Atat, Ashish Aneja, Samy I. McFarlane, James R. Sowers · 2003 · Endocrinology and Metabolism Clinics of North America
2. Angiotensin receptor blockers improve insulin resistance in type 2 diabetic rats by modulating adipose tissue
   Mi H. Lee, Hye Kyoung Song, Gang Jee Ko, Young Sun Kang, Sang Youb Han, Kum Hyun Han, Hyoung K. Kim, Jee‐Young Han, Dae R. Cha · 2008 · Kidney International
3. The Renin-Angiotensin System in the Pathophysiology of Type 2 Diabetes
   Gijs H. Goossens · 2012 · Obesity Facts
4. Angiotensin-Converting Enzyme Inhibition Intervention in Elderly Persons: Effects on Body Composition and Physical Performance
   C. S. Carter, Graziano Onder, Stephen B. Kritchevsky, M. Pahor · 2005 · The Journals of Gerontology Series A
5. Intrarenal Aminopeptidase N Inhibition Augments Natriuretic Responses to Angiotensin III in Angiotensin Type 1 Receptor–Blocked Rats
   Shetal H. Padia, Brandon A. Kemp, Nancy L. Howell, Helmy M. Siragy, Marie‐Claude Fournié‐Zaluski, Bernard Pierre Roques, Robert M. Carey · 2006 · Hypertension
6. Serum soluble (pro)renin receptor levels in patients with essential hypertension
   Satoshi Morimoto, Takashi Ando, Michita Niiyama, Yasufumi Seki, Naohiro Yoshida, Daisuke Watanabe, Fumiko Kawakami-Mori, Hiroyuki Kobori, Akira Nishiyama, Atsuhiro Ichihara · 2014 · Hypertension Research
7. Differential expression of angiotensin receptors in human cutaneous wound healing
   U. Muscha Steckelings, Beate M. Henz, S. Wiehstutz, Thomas Unger, Metin Artuc · 2005 · British Journal of Dermatology
8. Mitochondrial oxidative stress in obesity: role of the mineralocorticoid receptor
   Clara Lefranc, Malou Friederich‐Persson, Roberto Palacios, Aurélie Nguyen Dinh Cat · 2018 · Journal of Endocrinology
9. Role of the Renin-Angiotensin-Aldosterone System in the Pathogenesis of Atherosclerosis
   Alessandro Durante, Giovanni Peretto, Alessandra Laricchia, Francesco Ancona, Marco Spartera, Antonio Mangieri, Domenico Cianflone · 2012 · Current Pharmaceutical Design
10. Obesity-related hypertension: Epidemiology, pathophysiology, treatments, and the contribution of perivascular adipose tissue
    Reza Aghamohammadzadeh, Anthony Michael Heagerty · 2012 · Annals of Medicine
11. The Japanese Society of Hypertension Guidelines for the management of elevated blood pressure and hypertension 2025 (JSH2025)
    Yusuke Ohya, Kimika Arakawa, Naoko Arata, Shuji Arima, Hisatomi Arima, K. Asayama, Yasuaki Dohi, Ako Fukami, Masato Furuhashi, Kenichi Goto et al. · 2026 · Hypertension Research
12. Antioxidant-based therapies for angiotensin II-associated cardiovascular diseases
    Erin G. Rosenbaugh, Krupa K. Savalia, Devika Soundara Manickam, Matthew Christopher Zimmerman · 2013 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
13. Adiposopathy: why do adiposity and obesity cause metabolic disease?
    Harold Edward Bays, Christie Mitchell Ballantyne · 2006 · Future Lipidology
14. A Review on the Protective Effects of Honey against Metabolic Syndrome
    Nur Zuliani Ramli, Kok‐Yong Chin, Khairul Anwar Zarkasi, Fairus Ahmad · 2018 · Nutrients
15. Differential Effects of LocalVersusSystemic Angiotensin II in the Regulation of Leptin Release from Adipocytes
    Lisa Ann Cassis, Victoria L. English, Kalyani G. Bharadwaj, Carine Boustany · 2003 · Endocrinology
16. Control of Adipogenesis by the Autocrine Interplays between Angiotensin 1–7/Mas Receptor and Angiotensin II/AT1 Receptor Signaling Pathways
    Aung Than, Melvin Khee‐Shing Leow, Peng Chen · 2013 · Journal of Biological Chemistry
17. Human Adipose Tissue Cells Keep Tight Control on the Angiotensin II Levels in Their Vicinity
    Petra Schling, Thorsten Schäfer · 2002 · Journal of Biological Chemistry
18. Impact of the renin-angiotensin system on lipid and carbohydrate metabolism
    Strazzullo, Pasquale, Galletti, Ferruccio · 2004 · Current Opinion in Nephrology and Hypertension
19. The tissue renin–angiotensin system and intracellular signalling
    Ingrid Fleming, Karin Kohlstedt, Rudi Busse · 2005 · Current Opinion in Nephrology & Hypertension
20. Vitamin D3 Therapy Corrects the Tissue Sensitivity to Angiotensin II Akin to the Action of a Converting Enzyme Inhibitor in Obese Hypertensives: An Interventional Study
    Vaidya, Anand, Sun, Bei, Larson, Carol, Forman, John P., Williams, Jonathan S. · 2012 · The Journal of Clinical Endocrinology & Metabolism
21. Increased urinary angiotensin converting enzyme 2 and neprilysin in patients with type 2 diabetes
    Sridevi Gutta, Nadja Grobe, Meenasri Kumbaji, Hassan Osman, Mohammad G. Saklayen, Gengxin Li, Khalid M. Elased · 2018 · American Journal of Physiology-Renal Physiology
22. Cardiac Natriuretic Peptides, Hypertension and Cardiovascular Risk
    Riccardo Sarzani, Francesco Spannella, Federico Giulietti, Paolo Balietti, Guido Cocci, Marica Bordicchia · 2017 · High Blood Pressure & Cardiovascular Prevention
23. Comparison of circulating and local adipose tissue renin-angiotensin system in normotensive and hypertensive obese subjects
    Emanuela Faloia, Cristina Gatti, M. A. Camilloni, Barbara Mariniello, Cipriana Sardu, Gabriella Garrapa, Franco Mantero, Gilberta Giacchetti · 2002 · Journal of Endocrinological Investigation
24. Angiotensin II stimulates and atrial natriuretic peptide inhibits human visceral adipocyte growth
    Riccardo Sarzani, P Marcucci, Fabio Salvi, Marica Bordicchia, Emma Espinosa, Lucia Mucci, Barbara Lorenzetti, Daniele Minardi, Giovanni Muzzonigro, Paolo Dessı̀-Fulgheri et al. · 2007 · International Journal of Obesity
25. Renin-Angiotensin System: Updated Understanding and Role in Physiological and Pathophysiological States
    Ashok Kumar Kanugula, Jasleen Kaur, Jaskaran Batra, Anvitha Reddy Ankireddypalli, Ravikanth Velagapudi · 2023 · Cureus
26. Metabolic and Hemodynamic Response of Adipose Tissue to Angiotensin II
    Michael Boschmann, Jens Ringel, Susanne Klaus, Arya Mitra Sharma · 2001 · Obesity Research
27. Angiotensin-Converting Enzyme Inhibition, Body Composition, and Physical Performance in Aged Rats
    C. S. Carter, Matteo Cesari, Walter T. Ambrosius, N. Hu, Debra I. Diz, S. Oden, William Edmund Sonntag, M. Pahor · 2004 · The Journals of Gerontology Series A
28. Renin-angiotensin system polymorphisms in relation to hypertension status and obesity in a Tunisian population
    Sounira Mehri, Sinda Zarrouk‐Mahjoub, Sonia Ouali Hammami, Amira Zaroui, Ameur Frih, Fathi Betbout, Rachid Mechmèche, Mohamed Hammami · 2011 · Molecular Biology Reports
29. Left Ventricular Mass and Geometry in Adolescence
    Hanna Hietalampi, Katja Pahkala, Eero V. Jokinen, Tapani Rönnemaa, Jorma S.A. Viikari, Harri Niinikoski, Olli Juhani Heinonen, Pia Salo, Olli Simell, Olli Tuomas Raitakari · 2012 · Hypertension
30. Angiotensin 1–7 stimulates brown adipose tissue and reduces diet-induced obesity
    Hidechika Morimoto, Jun Mori, Hisakazu Nakajima, Yasuhiro Kawabe, Yusuke Tsuma, Shota Fukuhara, Kazuki Kodo, Kazuya Ikoma, Satoaki Matoba, Gavin Y. Oudit et al. · 2017 · American Journal of Physiology-Endocrinology and Metabolism
31. Obesity, insulin resistance and kidney disease risk: insights into the relationship
    P. Sarafidis · 2008 · Current opinion in nephrology and hypertension
32. Compliance costs, regulation, and environmental performance: Controlling truck emissions in the US
    Dorothy Thornton, Robert A. Kagan, NEIL A. GUNNINGHAM · 2008 · Regulation & Governance
33. Mechanisms linking the renin-angiotensin system, obesity, and breast cancer
    Fahmida Akter Rasha, Latha Ramalingam, Lauren Gollahon, Rakshanda L Rahman, Shaikh Mizanoor Rahman, Kalhara R. Menikdiwela, Naïma Moustaïd‐Moussa · 2019 · Endocrine Related Cancer
34. New developments in mechanisms of obesity-induced hypertension: Role of adipose tissue
    Arya Mitra Sharma, Stefan Engeli, Tobias Pischon · 2001 · Current Hypertension Reports
35. Maternal high-fat diet programs rat offspring hypertension and activates the adipose renin-angiotensin system
    Cristiane Guberman, Juanita K. Jellyman, Guang Han, Michael Glenn Ross, Mina Desai · 2013 · American Journal of Obstetrics and Gynecology
36. Is prehypertension an independent predictor of target organ changes in young-to-middle-aged persons of African descent?
    Gavin Robert Norton, Muzi Joseph Maseko, Elena N. Libhaber, Carlos D. Libhaber, Olebogeng H.I. Majane, Patrick Hector Dessein, Pinhas Sareli, Angela J. Woodiwiss · 2008 · Journal of Hypertension
37. The Local Regulation of Vascular Function: From an Inside-Outside to an Outside-Inside Model
    Eduardo Nava, Sílvia Llorens · 2019 · Frontiers in Physiology
38. (Pro)renin Receptor Inhibition Reprograms Hepatic Lipid Metabolism and Protects Mice From Diet-Induced Obesity and Hepatosteatosis
    Liwei Ren, Yuan Sun, Hong S. Lu, Dien Ye, Lijuan Han, Na Wang, Alan Daugherty, Furong Li, Miaomiao Wang, Fengting Su et al. · 2018 · Circulation Research
39. Selective reduction in body fat mass and plasma leptin induced by angiotensin-converting enzyme inhibition in rats
    Michael L. Mathai, S Naik, Andrew James Sinclair, Harrison Scott Weisinger, R. S. Weisinger · 2008 · International Journal of Obesity
40. Managing cardiovascular and renal risk: the potential of direct renin inhibition
    Peter Sever, Alan H. Gradman, Michel Azizi · 2009 · Journal of the Renin-Angiotensin-Aldosterone System
41. Obesity and COVID-19: A Perspective from the European Association for the Study of Obesity on Immunological Perturbations, Therapeutic Challenges, and Opportunities in Obesity
    Gijs H. Goossens, Dror Dicker, Nathalie J. Farpour‐Lambert, Gema Frühbeck, Dana Müllerová, Euan Woodward, Jens‐Christian Holm · 2020 · Obesity Facts
42. Angiotensin 1–7: A peptide for preventing and treating metabolic syndrome
    Sérgio Henrique Sousa Santos, João Marcus Oliveira Andrade · 2014 · Peptides
43. Angiotensin II regulates oxygen consumption
    Lisa Ann Cassis, Marc J Helton, Vicki English, Gerome Burke · 2002 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
44. Angiotensin receptor blockers in the treatment of NASH/NAFLD: Could they be a first-class option?
    Eugen Florin Georgescu · 2008 · Advances in Therapy
45. Lack of weight gain after angiotensin AT 1 receptor blockade in diet‐induced obesity is partly mediated by an angiotensin‐(1–7)/ M as‐dependent pathway
    Johanna Schuchard, Martina Winkler, Ines Stölting, Franziska Schuster, FLORIAN M. VOGT, Jörg Barkhausen, Christoph Thorns, Robson A.S. Santos, Michael Bäder, Walter Raasch · 2015 · British Journal of Pharmacology
46. Role of mineralocorticoid receptor and renin–angiotensin–aldosterone system in adipocyte dysfunction and obesity
    Alessandra Feraco, Andrea Armani, Caterina Mammi, Andrea Fabbri, Giuseppe M.C. Rosano, Massimiliano Caprio · 2013 · The Journal of Steroid Biochemistry and Molecular Biology
47. PPARγ: A Critical Determinant of Body Fat Distribution in Humans and Mice
    Yau-Sheng Tsai, Nobuyo Maeda · 2005 · Trends in Cardiovascular Medicine
48. Role of the Renin-Angiotensin System and Aldosterone on Cardiometabolic Syndrome
    Pablo Stiefel, Antonio J. Vallejo‐Vaz, José Salvador García Morillo, J. Villar · 2011 · International Journal of Hypertension
49. The emerging pleiotrophic role of adipokines in the uremic phenotype
    Juan Jesús Carrero, Antonio Carlos Cordeiro, Bengt Lindholm, Peter Stenvinkel · 2009 · Current Opinion in Nephrology & Hypertension
50. Obesity and cardiovascular disease: role of adipose tissue, inflammation, and the renin-angiotensin-aldosterone system
    Guido Lastra, James R. Sowers · 2013 · Hormone Molecular Biology and Clinical Investigation
51. The influence of body mass index and renin–angiotensin–aldosterone system activity on the relationship between 25-hydroxyvitamin D and adiponectin in Caucasian men
    Anand Vaidya, John P. Forman, PATRICIA C. UNDERWOOD, Paul Nathan Hopkins, Gordon H. Williams, Luminita H. Pojoga, Jonathan S. Williams · 2011 · European Journal of Endocrinology
52. Fetal Sex Affects Expression of Renin-Angiotensin System Components in Term Human Decidua
    Yu Wang, Kirsty G. Pringle, Shane D. Sykes, Francine Z. Marques, Brian J. Morris, Tamás Zakár, Eugenie Ruth Lumbers · 2011 · Endocrinology
53. Independent impact of obesity and fat distribution in hypertension prevalence and control in the elderly
    Josep Redón, Luis Cea‐Calvo, Basilio Moreno, Susana Monereo, Vicente Francisco Gil-Guillén, José Vicente Lozano, Juan C. Martí-Canales, José L Llisterri, José Aznar, Cristina Fernández · 2008 · Journal of Hypertension
54. Angiotensin II Enhances Insulin Sensitivity in Vitro and in Vivo
    Chi‐Chang Juan, Yueh Chien, Liang-Yi Wu, Wei-Ming Yang, Chih-Ling Chang, Ying‐Hsiu Lai, Pei‐Hsuan Ho, Ching‐Fai Kwok, Low-Tone Ho · 2005 · Endocrinology
55. Sympathetic Modulation by Carvedilol and Losartan Reduces Angiotensin II-Mediated Lipolysis in Subcutaneous and Visceral Fat
    Aderville Cabassi, Pietro Coghi, Paolo Govoni, E. Barouhiel, Ester Speroni, Stefania Cavazzini, Anna Maria Cantoni, R Scandroglio, Enrico Fiaccadori · 2005 · The Journal of Clinical Endocrinology & Metabolism
56. Low Dietary Sodium and Exogenous Angiotensin II Infusion Decrease Plasma Adiponectin Concentrations in Healthy Men
    A. Titia Lely, Jan A. Krikken, Stephan J. L. Bakker, Frans Boomsma, Robin P. F. Dullaart, Bruce H. R. Wolffenbuttel, Gerjan J Navis · 2007 · The Journal of Clinical Endocrinology & Metabolism
57. Varying Protein Source and Quantity do not Significantly Improve Weight Loss, Fat Loss, or Satiety in Reduced Energy Diets among Midlife Adults
    Aldrich, Noel D., Reicks, Marla M., Sibley, Shalamar D., Redmon, J. Bruce, Thomas, William, Raatz, Susan K. · 2011 · Nutrition Research
58. Vitamin D and the vascular sensitivity to angiotensin II in obese Caucasians with hypertension
    Vaidya, A, Forman, J P, Williams, J S · 2011 · Journal of Human Hypertension
59. Impact of blood pressure and insulin on the relationship between body fat and left ventricular structure
    Kristjan Karason · 2003 · European Heart Journal
60. Emerging concepts in the pathophysiology and treatment of obesity-associated hypertension
    Stefan Engeli, Arya Mitra Sharma · 2002 · Current Opinion in Cardiology
61. Long-term treatment with an angiotensin II receptor blocker decreases adipocyte size and improves insulin signaling in obese Zucker rats
    Marina Cecilia Muñoz, Jorge Fernando Giani, Fernando Pablo Dominici, Daniel Turyn, Jorge Eduardo Toblli · 2009 · Journal of Hypertension
62. Adipokines and Arterial Stiffness in Obesity
    Ioana Para, Adriana Albu, Mihai Dumitru Porojan · 2021 · Medicina
63. Association of the degree of adiposity and duration of obesity with measures of cardiac structure and function: The CARDIA study
    Jared P. Reis, Norrina B. Allen, Bethany Barone Gibbs, Samuel S. Gidding, Joyce M. Lee, Cora Elizabeth Lewis, João A.C. Lima, Donald M. Lloyd‐Jones, Catherine M. Loria, Tiffany M. Powell‐Wiley et al. · 2014 · Obesity
64. Blockade of the Renin-Angiotensin System Ameliorates Apelin Production in 3T3-L1 Adipocytes
    Wei‐Wen Hung, Tusty‐Jiuan Hsieh, Tzu Hung Lin, Pong-Chun Chou, Pi‐Jung Hsiao, Kun‐Der Lin, Shyi‐Jang Shin · 2010 · Cardiovascular Drugs and Therapy
65. Transcription Adaptation during In Vitro Adipogenesis and Osteogenesis of Porcine Mesenchymal Stem Cells: Dynamics of Pathways, Biological Processes, Up-Stream Regulators, and Gene Networks
    Massimo Bionaz, Elisa Lo Monaco, Matthew B. Wheeler · 2015 · PLoS ONE
66. Impact of body composition, fat distribution and sustained weight loss on cardiac function in obesity
    Dimitris Kardassis, Odd Bech‐Hanssen, Marie Schönander, Lars Sjöström, Max Petzold, Kristjan Karason · 2011 · International Journal of Cardiology
67. Possible Mechanisms of Local Tissue Renin-Angiotensin System Activation in the Cardiorenal Metabolic Syndrome and Type 2 Diabetes Mellitus
    Melvin Ray Hayden, Kurt M. R. Sowers, Lakshmi Pulakat, Tejaswini Joginpally, Bennett Krueger, Adam T. Whaley‐Connell, James R. Sowers · 2011 · Cardiorenal Medicine
68. The Association of Aldosterone With Obesity-Related Hypertension and the Metabolic Syndrome
    Bruno Vogt, Murielle Bochud, Michel Burnier · 2007 · Seminars in Nephrology
69. Screening of Obese Offspring of First-Cousin Consanguineous Subjects for the Angiotensin-Converting Enzyme Gene with a 287-bp Alu Sequence
    Amal F. Alshammary, Imran Ali Khan · 2021 · Journal of Obesity & Metabolic Syndrome
70. Insulin resistance in hypertension and cardiovascular disease
    Valéria Lamounier‐Zepter, Monika Ehrhart‐Bornstein, Stefan Richard Bornstein · 2006 · Best Practice & Research Clinical Endocrinology & Metabolism
71. Possible Involvement of Adipocyte-Derived Leucine Aminopeptidase via Angiotensin II in Endometrial Carcinoma
    Kiyosumi Shibata, Kiyosumi Shibata, Fumitaka Kikkawa, Fumitaka Kikkawa, Yayoi Mizokami, Yayoi Mizokami, Hiroaki Kajiyama, Hiroaki Kajiyama, Kazuhiko Ino, Kazuhiko Ino et al. · 2005 · Tumor Biology
72. Angiotensinogen Gene Silencing Reduces Markers of Lipid Accumulation and Inflammation in Cultured Adipocytes
    Wenting Xin Carroll, Nishan S. Kalupahana, Suzanne Lauren Booker, Nalin Siriwardhana, Monique J. LeMieux, Arnold M. Saxton, Naïma Moustaïd‐Moussa · 2013 · Frontiers in Endocrinology
73. Renin–angiotensin system overactivation in perivascular adipose tissue contributes to vascular dysfunction in heart failure
    Milene Tavares Fontes, Suliana Mesquita Paula, Caroline Antunes Lino, Nathalia Senger, Gisele Kruger Couto, Maria Luiza Morais Barreto‐Chaves, José Geraldo Mill, Luciana Venturini Rossoni · 2020 · Clinical Science
74. Endothelial cell-specific aryl hydrocarbon receptor knockout mice exhibit hypotension mediated, in part, by an attenuated angiotensin II responsiveness
    Larry N Agbor, Khalid M. Elased, Mary K. Walker · 2011 · Biochemical Pharmacology
75. Alterations of left ventricular myocardial strain in obese children
    Fabien Labombarda, E. Zangl, A. Dugué, Dominique L Bouglé, Arnaud Pellissier, V. Ribault, Pascale Maragnès, Paul Milliez, Éric Saloux · 2012 · European Heart Journal - Cardiovascular Imaging
76. Hierarchical analysis of anthropometric indices in the prediction of 5-year incidence of hypertension in apparently healthy adults: The ATTICA study
    Demosthenes B. Panagiotakos, Christina A. Chrysohoou, Christos S. Pitsavos, John Skoumas, Yannis Lentzas, Anastasia Katinioti, Christodoulos Stefanadis · 2009 · Atherosclerosis
77. Beneficial effects of physical exercise on hypertension and cardiovascular adverse remodeling of diet-induced obese rats
    Alessandra R. Pinheiro, Ana Rosa Cunha, Márcia Barbosa Águila, Carlos Alberto Mandarim‐de‐Lacerda · 2006 · Nutrition Metabolism and Cardiovascular Diseases
78. Cross Talk Between Adipose Tissue Cells: Impact on Pathophysiology
    Petra Schling, Georg Löffler · 2002 · Physiology
79. Angiotensinogen, adipocyte differentiation and fat mass enlargement
    Gerard P. Ailhaud, Michèle Teboul, Florence Massiéra · 2002 · Current Opinion in Clinical Nutrition & Metabolic Care
80. Angiotensin type-1 receptor blockade with losartan increases insulin sensitivity and improves glucose homeostasis in subjects with type 2 diabetes and nephropathy
    H.-M. Jin, Yu Pan · 2007 · Nephrology Dialysis Transplantation
81. Obesity
    Dinko Sušić, Jasmina Varagić · 2016 · Medical Clinics of North America
82. Açaí seed extract prevents the renin-angiotensin system activation, oxidative stress and inflammation in white adipose tissue of high-fat diet–fed mice
    Izabelle Barcellos Santos, Graziele Freitas de Bem, Cristiane Aguiar da Costa, Lenize Costa Reis Marins de Carvalho, Amanda Faria de Medeiros, Dafne Lopes Beserra Silva, Matheus Henrique Romão, Ricardo de Andrade Soares, Dayane Teixeira Ognibene, Roberto Soares de Moura et al. · 2020 · Nutrition Research
83. Adipose Tissue as an Endocrine Organ? A Review of Recent Data Related to Cardiovascular Complications of Endocrine Dysfunctions
    Paola Pantanetti, Gabriella Garrapa, Franco Mantero, Marco Boscaro, Emanuela Faloia, Domenico Venarucci · 2004 · Clinical and Experimental Hypertension
84. How Economists Use Literature and Drama
    Michael Wattsee · 2002 · The Journal of Economic Education
85. Preeclampsia and Obesity—The Preventive Role of Exercise
    Elżbieta Poniedziałek‐Czajkowska, Radzisław Mierzyński, Bożena Leszczyńska‐Gorzelak · 2023 · International Journal of Environmental Research and Public Health
86. PPARγ Pro12Ala and ACE ID polymorphisms are associated with BMI and fat distribution, but not metabolic syndrome
    Angelina Passaro, Edoardo Dalla Nora, Caterina Marcello, Francesca Di Vece, Mario Luca Morieri, Juana María Sanz, Cristina Bosi, R. Fellin, Giovanni Zuliani · 2011 · Cardiovascular Diabetology
87. Inactivation of adipose angiotensinogen reduces adipose tissue macrophages and increases metabolic activity
    Monique J. LeMieux, Latha Ramalingam, Randall L. Mynatt, Nishan S. Kalupahana, Hyun Jung Kim, Naïma Moustaïd‐Moussa · 2015 · Obesity
88. ACE2 as a Therapeutic Target for COVID-19; Its Role in Infectious Processes and Regulation by Modulators of the RAAS System
    Véronique Michaud, Malavika Deodhar, Meghan J. Arwood, Sweilem B. Al Rihani, Pamela Dow, Jacques Turgeon · 2020 · Journal of Clinical Medicine
89. Molecular Cloning and Sequencing of the cDNA for Rat Mesenteric Arterial Bed Elastase-2, an Angiotensin II–Forming Enzyme
    Carlos Ferreira Santos, Eduardo Brandt Oliveira, Maria Cristina O. Salgado, Andrew Seth Greene · 2002 · Journal of Cardiovascular Pharmacology
90. Association of angiotensin-converting enzyme insertion/deletion polymorphism with obesity, cardiovascular risk factors and exercise-mediated changes in Korean women
    Kijin Kim · 2009 · European Journal of Applied Physiology
91. The ACE insertion/deletion polymorphism and its association with metabolic syndrome
    Bo Xi, Rikje Ruiter, Jie Chen, Haiyan Pan, Ying Wang, Jie Mi · 2011 · Metabolism
92. Obesity and the increased risk for COVID-19: mechanisms and nutritional management
    Ana Heloneida de Araújo Morais, Thaís Souza Passos, Sancha Helena de Lima Vale, Juliana Kelly da Silva-Maia, Bruna Leal Lima Maciel · 2020 · Nutrition Research Reviews
93. Combination of Captopril and Allopurinol Retards Fructose-Induced Metabolic Syndrome
    Carlos A. Roncal, Sirirat Reungjui, Laura Gabriela Sánchez‐Lozada, Wei Mu, Yuri Y. Sautin, Takahiko Nakagawa, Richard J. Johnson · 2009 · American Journal of Nephrology
94. Fibroblast Growth Factor 23, Mineral Metabolism, and Adiposity in Normal Kidney Function
    Sarah Zaheer, Ian H. de Boer, Matthew Allison, Jenifer Michelle Brown, Bruce M. Psaty, Cassianne Robinson‐Cohen, Erin D. Michos, Joachim H. Ix, Bryan R. Kestenbaum, David S. Siscovick et al. · 2017 · The Journal of Clinical Endocrinology & Metabolism
95. Non-pharmacological factors for hypertension management: a systematic review of international guidelines
    Carmela Maniero, Aleksandra Lopuszko, Kyriaki-Barbara Papalois, Ajay Kumar Gupta, Vikas Kapil, Mohammed Yunus Khanji · 2022 · European Journal of Preventive Cardiology
96. Human adipocytes attenuate cardiomyocyte contraction: characterization of an adipocyte‐derived negative inotropic activity
    Valéria Lamounier‐Zepter, Monika Ehrhart‐Bornstein, Peter Karczewski, Hannelore Haase, Stefan Richard Bornstein, Ingo L. Morano · 2006 · The FASEB Journal
97. Adipose tissue–specific dysregulation of angiotensinogen by oxidative stress in obesity
    Sadanori Okada, Chisayo Kozuka, Hiroaki Masuzaki, Shintaro Yasue, 米本崇子, Tomohiro Tanaka, Yuji Yamamoto, Michio Noguchi, Toru Kusakabe, Tsutomu Tomita et al. · 2010 · Metabolism
98. Plasma Aldosterone Is Increased in Class 2 and 3 Obese Essential Hypertensive Patients Despite Drug Treatment
    Riccardo Sarzani, Federico Guerra, Lucia Mancinelli, Alessia Buglioni, E. Franchi, Paolo Dessı̀-Fulgheri · 2012 · American Journal of Hypertension
99. A Review of Posttraumatic Stress Disorder and Obesity
    Kanaklakshmi Masodkar, Justine A. Johnson, Michael J. Peterson · 2016 · The Primary Care Companion For CNS Disorders
100. Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with metabolic syndrome in Iranians with type 2 diabetes mellitus.
     Abdolrahim Nikzamir, Manouchehr Nakhjavani, Taghi Golmohamadi, Ladan Dibai · 2008 · PubMed